Estrace: Effective Estrogen Therapy for Menopausal Symptom Relief
Estrace
| Product dosage: 1mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | 1.07 $ | 64.35 $ (0%) | 🛒 Add to cart |
| 90 | 0.97 $ | 96.53 $ 87.75 $ (9%) | 🛒 Add to cart |
| 120 | 0.93 $ | 128.70 $ 111.15 $ (14%) | 🛒 Add to cart |
| 180 | 0.88 $ | 193.05 $ 157.95 $ (18%) | 🛒 Add to cart |
| 270 | 0.84 $ | 289.57 $ 228.15 $ (21%) | 🛒 Add to cart |
| 360 | 0.83 $
Best per pill | 386.10 $ 298.35 $ (23%) | 🛒 Add to cart |
Estrace is a prescription medication containing estradiol, a bioidentical form of estrogen, designed to address the hormonal imbalances associated with menopause. It is indicated for the management of moderate to severe vasomotor symptoms, such as hot flashes and night sweats, as well as vulvar and vaginal atrophy. By replenishing declining estrogen levels, Estrace helps restore physiological balance and improve quality of life for women experiencing menopausal transition. This therapy is available in various formulations, including oral tablets and topical creams, allowing for personalized treatment approaches under medical supervision.
Features
- Contains 17β-estradiol, a bioidentical estrogen
- Available in oral tablet and topical cream formulations
- Multiple dosage strengths for individualized dosing
- Micronized formulation for enhanced bioavailability
- pH-balanced topical cream for vaginal application
- Manufactured under strict pharmaceutical quality standards
Benefits
- Effectively reduces frequency and severity of hot flashes
- Alleviates vaginal dryness, itching, and discomfort
- Helps prevent postmenopausal osteoporosis
- Improves sleep quality disrupted by night sweats
- Enhances overall quality of life during menopausal transition
- Supports urogenital health and comfort
Common use
Estrace is primarily prescribed for the management of moderate to severe vasomotor symptoms associated with menopause, including hot flashes, night sweats, and flushes. It is also indicated for the treatment of vulvar and vaginal atrophy, which can cause dryness, burning, itching, and discomfort during intercourse. Additionally, Estrace may be prescribed for the prevention of postmenopausal osteoporosis in women at significant risk who cannot tolerate non-estrogen medications. Some healthcare providers may use Estrace off-label for other estrogen-deficiency conditions under careful medical supervision.
Dosage and direction
The dosage of Estrace must be individualized based on the patient’s symptoms, response to therapy, and medical history. For oral tablets: The usual starting dose is 1-2 mg daily, which may be adjusted based on symptom control. For vaginal cream: The usual dose is 2-4 g daily for one to two weeks, then gradually reduced to half the initial dose for a similar period. A maintenance dose of 1 g, one to three times weekly, may be prescribed after restoration of vaginal tissue has been achieved. Tablets should be taken at the same time each day, with or without food. Vaginal cream should be applied using the provided applicator according to the physician’s instructions. Treatment should be administered at the lowest effective dose for the shortest duration consistent with treatment goals.
Precautions
Patients using Estrace should undergo regular medical examinations, including breast exams and mammograms as appropriate for their age and risk factors. Blood pressure should be monitored regularly during therapy. Estrace should be used with caution in patients with conditions that might be influenced by fluid retention, such as asthma, epilepsy, migraine, or cardiac or renal dysfunction. Patients with a history of depression should be closely monitored. Those requiring thyroid hormone replacement therapy may need dosage adjustments, as estrogen may increase thyroid-binding globulin levels. Caution is advised when prescribing to patients with impaired liver function, diabetes, or gallbladder disease.
Contraindications
Estrace is contraindicated in women with known or suspected pregnancy, as estrogen use during pregnancy may cause fetal harm. It is also contraindicated in patients with known or suspected estrogen-dependent neoplasia, such as breast cancer (except in specific palliative situations under specialist care). Additional contraindications include undiagnosed abnormal genital bleeding, active or history of arterial thromboembolic disease, active or recent venous thromboembolism, liver dysfunction or disease, and known hypersensitivity to any component of the formulation. Estrace should not be used in patients with known or suspected pregnancy.
Possible side effect
Common side effects may include headache, breast tenderness or enlargement, nausea, vomiting, abdominal cramps, bloating, changes in weight, changes in libido, nervousness, mood changes, and irregular vaginal bleeding or spotting. Less common but more serious side effects may include sudden numbness or weakness, sudden severe headache, chest pain, coughing up blood, pain or swelling in one leg, changes in vision, jaundice, lumps in the breast, unusual vaginal bleeding, or depression. Topical application may cause local irritation, itching, or burning. Patients should report any persistent or severe side effects to their healthcare provider immediately.
Drug interaction
Estrace may interact with several medications, including CYP3A4 inducers such as carbamazepine, phenobarbital, phenytoin, rifampin, and St. John’s wort, which may decrease estrogen concentrations. Conversely, strong CYP3A4 inhibitors may increase estrogen levels. Estrogen may affect the metabolism of other drugs, including corticosteroids, cyclosporine, and theophylline. Anticoagulants may have their effects altered by estrogen therapy. Thyroid hormone requirements may change in patients receiving both medications. The effectiveness of oral contraceptives may be affected. Patients should inform their healthcare provider of all medications, including over-the-counter drugs and herbal supplements.
Missed dose
If a dose of oral Estrace is missed, it should be taken as soon as remembered unless it is almost time for the next dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not double the dose to make up for a missed one. For vaginal cream, if a dose is missed, apply it as soon as possible unless it is near the time for the next application. Do not use extra cream to make up for a missed dose. Consistently missed doses may reduce the effectiveness of treatment, and patients should discuss any pattern of missed doses with their healthcare provider.
Overdose
Estrogen overdose may cause nausea, vomiting, breast tenderness, abdominal pain, drowsiness, fatigue, and withdrawal bleeding in women. There have been no reports of serious ill effects from acute overdose. Treatment should be symptomatic and supportive. Gastric lavage may be considered if ingestion was recent. Medical attention should be sought immediately if overdose is suspected. Long-term excessive dosing may increase the risk of more serious adverse effects associated with estrogen therapy, including thromboembolic events and endometrial cancer.
Storage
Estrace tablets should be stored at controlled room temperature (20-25°C or 68-77°F) in their original container, protected from light and moisture. The vaginal cream should be stored at room temperature, avoiding extreme heat or cold. Do not freeze. Keep all medications out of reach of children and pets. Do not use Estrace beyond the expiration date printed on the packaging. Properly discard any unused medication that is no longer needed or has expired according to local guidelines for medication disposal.
Disclaimer
This information is provided for educational purposes only and is not intended as medical advice. Estrace is a prescription medication that should be used only under the supervision of a qualified healthcare provider. Individual results may vary, and not all patients will experience the same benefits or side effects. Patients should consult with their healthcare provider for personalized medical advice and to discuss whether Estrace is appropriate for their specific medical condition. The safety and effectiveness of Estrace in pediatric patients have not been established.
Reviews
Clinical studies and patient reports indicate that Estrace is generally effective in managing menopausal symptoms, with many women experiencing significant improvement in hot flashes and vaginal discomfort. Patients often report improved quality of life and better sleep patterns. Some users note initial side effects that typically diminish with continued use. Healthcare providers generally consider Estrace a valuable option in menopausal hormone therapy when appropriately prescribed and monitored. Individual experiences may vary based on dosage, formulation, and personal health factors. Patients are encouraged to discuss their treatment experience with their healthcare provider to optimize therapy.